Quantcast

Latest Embryonic stem cell Stories

2014-07-24 16:26:46

- Tuesday, July 29, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT - MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host a live webcast of a presentation to investors on Tuesday, July 29, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT. The presentation will include an overview of Asterias' business strategy and product development pipeline. To...

Discovery Of Gene May Make It Easier To Develop Life-saving Stem Cells
2014-07-21 03:53:38

Michigan State University Not unlike looking for the proverbial needle in a haystack, a team of Michigan State University researchers have found a gene that could be key to the development of stem cells – cells that can potentially save millions of lives by morphing into practically any cell in the body. The gene, known as ASF1A, was not discovered by the team. However, it is at least one of the genes responsible for the mechanism of cellular reprogramming, a phenomenon that can turn...

2014-07-17 23:05:39

According to a new report from BCC Research, the global market for induced pluripotent stem cells (iPSCs) is expected to grow to $2.9 billion by 2018, with a five-year compound annual growth rate (CAGR) of 19.7%. The Asia-Pacific market, the fastest performing regional segment, is projected to move at a significant CAGR of 22%. (PRWEB) July 17, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, INDUCED PLURIPOTENT STEM CELLS: GLOBAL MARKETS, the global market for...

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-07-16 12:27:46

EWING, N.J., July 16, 2014 /PRNewswire/ -- Essential Pharmaceuticals LLC, Ewing NJ announces the release of Cell-Ess® serum replacement for cell culture. Cell-Ess is a replacement for the Fetal Bovine Serum (FBS) that is commonly used in cell culture. The product is chemically defined, animal component free and delivers critical components that are needed for cell growth. http://photos.prnewswire.com/prnvar/20140715/127335 Cell-Ess enables researchers to eliminate FBS use in...

2014-07-15 12:28:25

Accepted to stem cell treatment, but insurance won't cover it POLLOCK PINES, Calif., July 15, 2014 /PRNewswire/ -- Marc Serchia, 56, is waiting on a miracle, and if the doctors are correct he doesn't have much more time. At the age of 39, Marc suffered a massive heart attack, faced a 5-hour surgery to repair blocked arteries, and died on the surgical table six separate times. Unbelievably, he survived, but with a severely damaged heart. Doctors wouldn't put him near the top of the...

2014-07-10 12:34:40

Centro Nacional de Investigaciones Oncologicas (CNIO) The pluripotency factor NANOG regulates cell proliferation in epithelia of the skin and oesophagus in adult organisms; blocking the action of the gene diminishes the capacity of tumour cells to divide Scientists from the Spanish National Cancer Research Centre (CNIO) have discovered that NANOG, an essential gene for embryonic stem cells, also regulates cell division in stratified epithelia—those that form part of the epidermis of...

2014-07-09 12:30:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Induced Pluripotent Stem Cells : Global Marketshttps://www.reportbuyer.com/product/2212008/Induced-Pluripotent-Stem-Cells--Global-Markets.html This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes...

Stopping Spread Of Cancer By Blocking Cells' Movement
2014-07-07 03:13:10

University College London Insights into how cells move through the body could lead to innovative techniques to stop cancer cells from spreading and causing secondary tumors, according to new UCL research. Scientists discovered that cells can change into an invasive, liquid-like state to readily navigate the narrow channels in our body. This transformation is triggered by chemical signals, which could be blocked in order to stop cancer cells from spreading. Most cancer deaths are not...

Nuclear Transfer Proven An Effective Method In Stem Cell Production
2014-07-03 07:02:00

redOrbit Staff & Wire Reports - Your Universe Online A new process known as “somatic cell nuclear transfer” is far better and much more accurate when it comes to coaxing embryonic stem cells out of human skin tissue, according to new research appearing in Tuesday’s edition of the journal Nature. Scientists from Oregon Health & Science University (OHSU), the University of California-San Diego (UCSD) School of Medicine and the Salk Institute for Biological Studies created...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related